Details of the Drug

General Information of Drug (ID: DM3DGSG)

Drug Name
Lemborexant
Synonyms E2006
Indication
Disease Entry ICD 11 Status REF
Insomnia 7A00-7A0Z Approved [1]
Alzheimer disease 8A20 Phase 2 [2]
Affected Organisms
Humans and other mammals
ATC Code
N05CM21: Lemborexant
N05CM: Other hypnotics and sedatives
N05C: HYPNOTICS AND SEDATIVES
N05: PSYCHOLEPTICS
N: NERVOUS SYSTEM
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C22H20F2N4O2
Canonical SMILES
CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C
InChI
InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1
InChIKey
MUGXRYIUWFITCP-PGRDOPGGSA-N
Cross-matching ID
PubChem CID
56944144
ChEBI ID
CHEMBL3545367
CAS Number
1369764-02-2
UNII
0K5743G68X
DrugBank ID
DB11951
TTD ID
D0A7ZK
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)